The Center for Cancer Research and Advanced Therapies (CITAC) takes an important step forward by celebrating its first board meeting at the University of Málaga. This ambitious public-private project aims to establish itself as a leader in cancer research. During this meeting, two new board members, the Provincial Council of Málaga and the Fundación Mecenas de la Casa Natal Picasso, joined alongside key institutions such as the University of Málaga, the Málaga City Council, Fundación Unicaja, Unicaja Banco, FGUMA, Fundación SANDO, Famadesa, and Fundación Kareema.
Led by the renowned oncologist Emilio Alba, this innovative project aims to become a world-class center for cancer research located at the CIMES of the University of Málaga, specifically designed to attract and retain scientific talent. With a flexible structure and a scientific committee of national experts, CITAC is prepared to address the current and future challenges in oncology.
CITAC’s Strategic Objectives:
- Promote early cancer diagnosis and study its relationship with aging.
- Attract and retain research talent to advance knowledge in oncology.
- Adapt nimbly to current and future challenges in cancer research.
Thus, Málaga strengthens its position as a strategic hub for translational research, supported by the UMA Medical Oncology Group and CIMES, a center with advanced infrastructure and cutting-edge technology.
This endeavor represents Málaga and its institutions’ strong commitment to scientific innovation and improving quality of life, creating a significant impact at the national and international levels.
At Fundación Kareema, we are proud to be part of this project, which seeks to transform cancer research and treatment in Spain and beyond.
More information online: